Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Cichocki

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activityAkhilesh Kumar, Bin Zhang, Andrew Baldys, et al.
Cancer Immunology Research|May 23, 2018
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37Dhifaf Sarhan, Keli L Hippen, Amanda Lemire, et al.
Transplantation and Cellular Therapy|April 10, 2021
Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple MyelomaAimee M Merino, Rohtesh S Mehta, Xianghua Luo, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2023
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and ImmunotherapyDaheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, et al.
Cancer Immunology Research|February 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid TumorsJohn R Lozada, Atef Ali, Christine Luo, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Cytotherapy|April 24, 2021
Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustionKeli L Hippen, Scott N Furlan, Rahul Roychoudhuri, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Blood|August 2, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemiaFrank Cichocki, Jodie P Goodridge, Ryan Bjordahl, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2025
The transcription factor BCL11B drives NK cell cytotoxicity and antitumor activityAkhilesh Kumar, Bin Zhang, Andrew Baldys, et al.
Cancer Immunology Research|May 23, 2018
Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37Dhifaf Sarhan, Keli L Hippen, Amanda Lemire, et al.
Transplantation and Cellular Therapy|April 10, 2021
Early Adaptive Natural Killer Cell Expansion Is Associated with Decreased Relapse After Autologous Transplantation for Multiple MyelomaAimee M Merino, Rohtesh S Mehta, Xianghua Luo, et al.
Blood|February 11, 2012
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9Michelle K Gleason, Todd R Lenvik, Valarie McCullar, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 29, 2023
Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and ImmunotherapyDaheui Choi, Alan M Gonzalez-Suarez, Mihai G Dumbrava, et al.
Cancer Immunology Research|February 27, 2026
Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid TumorsJohn R Lozada, Atef Ali, Christine Luo, et al.
Immunity|March 19, 2015
Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector functionHeinrich Schlums, Frank Cichocki, Bianca Tesi, et al.
Cytotherapy|April 24, 2021
Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustionKeli L Hippen, Scott N Furlan, Rahul Roychoudhuri, et al.
Immunity|April 8, 2018
Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer CellsKristina S Burrack, Matthew A Huggins, Emily Taras, et al.
Blood|August 2, 2022
Dual antigen-targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemiaFrank Cichocki, Jodie P Goodridge, Ryan Bjordahl, et al.
Pageof 7